Mga Batayang Estadistika
| LEI | 549300JCNCTXXAG8MR63 |
| CIK | 874710 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Allied Healthcare Product Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| July 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 12, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| May 15, 2023 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-19266 NOTIFICATION OF LATE FILING CUSIP NUMBER 019222 10 8 (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Tran |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 12, 2023 Date of earliest event reported: May 7, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or other jurisdiction of incorporati |
|
| May 12, 2023 |
Exhibit 10.3 Debtor-In-Possession LOAN Agreement (TENTH Amendment to Loan and Security Agreement) This DEBTOR-IN-POSSESSION LOAN AGREEMENT (this “DIP Loan Agreement”), dated effective as of [ , 2023] (the “Effective Date”), is made and entered into by and between STERLING COMMERCIAL CREDIT, LLC, a Delaware limited liability company and successor in interest to Summit Financial Resources, LLC., a D |
|
| May 12, 2023 |
Exhibit 10.2 Asset Purchase Agreement -New York by and between Allied Healthcare Products, Inc., as Seller and Allied Medical, LLC, As Purchaser Dated as of May 7, 2023 TABLE OF CONTENTS ARTICLE I – DEFINITIONS 1 Section 1.1 Defined Terms 1 Section 1.2 Other Interpretive Provisions 11 ARTICLE II – PURCHASE AND SALE 11 Section 2.1 Purchase and Sale of Assets 11 Section 2.2 Purchased Assets 11 Secti |
|
| May 12, 2023 |
Exhibit 10.1 Asset Purchase Agreement – St. Louis by and between Allied Healthcare Products, Inc., as Seller and Allied Medical, LLC, as Purchaser Dated as of May 7, 2023 TABLE OF CONTENTS ARTICLE I – DEFINITIONS 1 Section 1.1 Defined Terms 1 Section 1.2 Other Interpretive Provisions 11 ARTICLE II – PURCHASE AND SALE 11 Section 2.1 Purchase and Sale of Assets 11 Section 2.2 Purchased Assets 11 Sec |
|
| May 12, 2023 |
Exhibit 99.1 Allied Healthcare Products Enters into Asset Purchase Agreement and Commences Voluntary Chapter 11 Proceedings to Facilitate Value Maximizing Sale Receives commitment for $4 million in debtor-in-possession financing to support ongoing operations St. Louis, MO—May 11, 2023— Allied Healthcare Products, Inc. (“AHP” or the “Company”), a reputable and leading manufacturer of medical gas co |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 14, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| March 16, 2023 |
NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENT AND FORBEARANCE Exhibit 99.1 EXECUTION VERSION NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENT AND FORBEARANCE THIS NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENT AND FORBEARANCE (this “Ninth Amendment”) is dated as of March 9, 2023 (the “Effective Date”), by and between the following (hereinafter sometimes collectively referred to as the “Parties” or individually as a “Party”): ALLIED HEALTHCARE PRODUCTS, INC., a |
|
| March 16, 2023 |
Exhibit 99.2 Allied Healthcare Products Announces Strategic Transformation Initiatives to Rebuild and Accelerate Performance Company to restart operations under new leadership with intensified focus on improving operational efficiencies to help drive growth and profitability Secures new senior secured credit facility to support ongoing operations St. Louis, MO – March 16, 2023 – Allied Healthcare |
|
| February 27, 2023 |
SEVENTH Amendment to Loan and Security Agreement Exhibit 99.1 SEVENTH Amendment to Loan and Security Agreement THIS SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (the “Seventh Amendment”) is hereby entered into and deemed effective as of February 19, 2023 (the “Effective Date”), by and between the following (hereinafter sometimes collectively referred to as the “Parties” or individually as a “Party”): ALLIED HEALTHCARE PRODUCTS, INC., a Delaw |
|
| February 27, 2023 |
Exhibit 99.2 INDEMNIFICATION AGREEMENT AGREEMENT, effective as of the date set forth below, between Allied Healthcare Products, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Indemnitee”). WHEREAS, it is essential to the Company to retain and attract as directors and officers the most capable persons available; and WHEREAS, Indemnitee is a director or officer of the Compan |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 22, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| February 14, 2023 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 14, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-19266 NOTIFICATION OF LATE FILING CUSIP NUMBER 019222 10 8 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR For Period Ended: December 31, 2022 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Rep |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 31, 2023 |
Sixth Amendment to Loan and Security Agreement Exhibit 99.1 Sixth Amendment to Loan and Security Agreement THIS SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (the “Sixth Amendment”) is executed on January 30, 2023 (the “Effective Date”), by and between the following (hereinafter sometimes collectively referred to as the “Parties” or individually as a “Party”): ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation (“Borrower”) and SUMMIT FI |
|
| January 31, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| January 31, 2023 |
Exhibit 99.2 Allied Healthcare Products, Inc. Amends Credit Agreement and Provides More Information Regarding Nasdaq Delisting St. Louis, Missouri, January 31, 2023 – On January 31, 2023, Allied Healthcare Products, Inc. (the “Company”) announced that it had entered into an amendment (the “Amendment”) to the Company’s Loan and Security Agreement with Summit Financial Resources, LLC (“Summit”) date |
|
| January 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 25, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| January 26, 2023 |
Allied Healthcare Products, Inc. Receives Nasdaq Deficiency Notice Exhibit 99.1 Allied Healthcare Products, Inc. Receives Nasdaq Deficiency Notice St. Louis, Missouri, January 26, 2023 – On January 25, 2023, the Board of Directors (the “Board”) of Allied Healthcare Products, Inc. (the “Company” or “Allied”) approved a plan of disposal of all or substantially all of the assets of the Company (the “Disposition Plan”). The Board has engaged the firm of Morris Anders |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 9, 2023 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Comm |
|
| December 22, 2022 |
Material Impairments, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 19, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 9, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 23, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 28, 2022 |
Allied Healthcare Products, Inc. Receives Nasdaq Deficiency Notice Exhibit 99.1 Allied Healthcare Products, Inc. Receives Nasdaq Deficiency Notice St. Louis, Missouri, November 28, 2022 - Allied Healthcare Products, Inc. (the ?Company?) today announced that on November 23, 2022 it received written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that, as a result of its delay in filing its Form 10-Q for the quarte |
|
| November 15, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of Company as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-19266 NOTIFICATION OF LATE FILING CUSIP NUMBER 019222 10 8 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR ? Form N-CSR For Period Ended: September 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? |
|
| October 12, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Ru |
|
| October 7, 2022 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| October 7, 2022 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Joseph F. |
|
| September 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-19266 NOTIFICATION OF LATE FILING CUSIP NUMBER 019222 10 8 (Check one): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Trans |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 22, 2022 |
Exhibit 99.2 COMMERCIAL LEASE THIS COMMERCIAL LEASE (?Lease?) made and entered into as of the 21st day of June, 2022, by and between Fyler Storage Properties, LLC, a Missouri limited liability corporation (hereinafter referred to as ?LESSOR?) AND Allied Healthcare Products, Inc., a Delaware corporation (hereinafter referred to as ?LESSEE?). WITNESSETH, that the said LESSOR for and in consideration |
|
| June 22, 2022 |
Exhibit 99.1 PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT (this ?Contract?) is made and dated as of the date upon which the last of Purchaser and Seller has executed this Contract as set forth on the signature page of this Contract (the ?Effective Date?), by and between Fyler Storage Properties, LLC, a Missouri limited liability company, as purchaser (?Purchaser?), and Allied Healt |
|
| June 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 14, 2022 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 14, 2022 |
Fifth Amendment to Loan and Security Agreement Exhibit 99.1 Fifth Amendment to Loan and Security Agreement This Fifth Amendment to Loan and Security Agreement (the "Amendment") is made and entered into by and between SUMMIT FINANCIAL RESOURCES, LLC, a Delaware limited liability company and the successor in interest to SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership ("Lender"), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware cor |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| December 2, 2021 |
AHPI / Allied Healthcare Products Inc / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authoriz |
|
| November 30, 2021 |
AHPI / Allied Healthcare Products Inc / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authoriz |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 7, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Comm |
|
| October 13, 2021 |
Fourth Amendment to Loan and Security Agreement Exhibit 99.1 Fourth Amendment to Loan and Security Agreement This Fourth Amendment to Loan and Security Agreement (the "Amendment") is made and entered into by and between SUMMIT FINANCIAL RESOURCES, LLC, a Delaware limited liability company and the successor in interest to SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership ("Lender"), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware c |
|
| October 8, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of theSecurities Exchange Act of 1934 (Amendment No.??????) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? Confidential, for Use of the Commission Only (as permitted by |
|
| September 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 28, 2021 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Joseph F. |
|
| September 3, 2021 |
AHPI / Allied Healthcare Products Inc / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| July 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 6, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 1, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| April 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 20, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| April 21, 2021 |
Exhibit 99.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into effective as of the 30th day of April, 2021 by and between JOSEPH F. ONDRUS, JR. (“Executive”) and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation, for itself and on behalf of any of its current or future subsidiary corporations (collectively referred to in this Agreement as the “Company”). |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 25, 2021 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| December 22, 2020 |
Third Amendment to Loan and Security Agreement Exhibit 99.1 Third Amendment to Loan and Security Agreement This Third Amendment to Loan and Security Agreement (the "Amendment") is made and entered into by and between SUMMIT FINANCIAL RESOURCES, LLC, a Delaware limited liability company and the successor in interest to SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership ("Lender"), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware cor |
|
| December 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 18, 2020 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2020 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 28, 2020 |
AHPI / Allied Healthcare Products, Inc. / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| October 23, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2020 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| October 9, 2020 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| October 5, 2020 |
AHPI / Allied Healthcare Products, Inc. / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| September 28, 2020 |
Exhibit 10.8 PROMISSORY NOTE (Commercial-Single Advance) DATE AND PARTIES. The date of this Promissory Note (Note) is April 13, 2020. The parties and their addresses are: LENDER: JEFFERSON BANK AND TRUST COMPANY 2301 Market Street Saint Louis, MO 63103 Telephone: 314-621-0100 BORROWER: ALLIED HEALTHCARE PRODUCTS, INC. a Missouri Corpooration 1720 Sublette Ave. Saint Louis, MO 63110 1. DEFINITIONS. |
|
| September 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 28, 2020 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 15, 2020 |
AHPI / Allied Healthcare Products, Inc. / WEIL JOHN D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| June 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 15, 2020 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 15, 2020 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC / Weil John D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| June 5, 2020 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC / Weil John D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| June 3, 2020 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC / Weil John D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| May 22, 2020 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC / Weil John D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| May 15, 2020 |
Exhibit 10.8 LOAN NUMBER 5310597103 LOAN NAME ALLIED HEALTHCARE PRODUCTS, INC. ACCT. NUMBER AAA0992 NOTE DATE 04/13/20 INITIALS DLD NOTE AMOUNT $2,374,859.00 INDEX (w/Margin) Not Applicable RATE 1.000% Creditor Use MATURITY DATE 4/13/2022 LOAN PURPOSE Commercial PROMISSORY NOTE (Commercial-Single Advance) DATE AND PARTIES. The date of this Promissory Note (Note) is April 13, 2020. The parties and |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| April 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 22, 2020 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| February 14, 2020 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| December 30, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 27, 2019 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 14, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 7, 2019 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| October 7, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC DEF 14A - - DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| September 27, 2019 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 27, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 27, 2019 |
Exhibit 4 Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 General The Company’s authorized capital stock currently consists of: - 30,000,000 shares of common stock, $0. |
|
| July 9, 2019 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 8, 2019 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 24, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 19, 2019 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| May 29, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC SD - - FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| May 15, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| April 25, 2019 |
Second Amendment to Loan and Security Agreement Exhibit 99.1 Second Amendment to Loan and Security Agreement This Second Amendment to Loan and Security Agreement (the “Amendment”) is made and entered into by and between SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership (“Lender”), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation (“Borrower”). Recitals A. Lender and Borrower have entered into a Loan and Security Agreemen |
|
| April 25, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 24, 2019 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 14, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC / Weil John D - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 4625 Lindell Blvd. Suite # 335 St Louis MO 63108 (314) 421-4600 (Name, Address and Telephone Number of Person Authorize |
|
| February 14, 2019 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 14, 2018 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 9, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2018 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| October 5, 2018 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC DEFINITIVE PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| September 28, 2018 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 28, 2018 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| May 30, 2018 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| May 30, 2018 |
Exhibit 1.01 Conflict Minerals Report This Conflict Minerals Report (“Report”) of Allied Healthcare Products, Inc., a Delaware corporation (“Allied”, the “Company”, “we”, or “us”) for the year ended December 31, 2017 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (“Rule”). Certain terms in this Report are defined in the Rule and our Specialized Disclosure Report o |
|
| May 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| April 20, 2018 |
First Amendment to Loan and Security Agreement Exhibit 99.1 First Amendment to Loan and Security Agreement This First Amendment to Loan and Security Agreement (the “Amendment”) is made and entered into by and between SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership (“Lender”), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation (“Borrower”). Recitals A. Lender and Borrower have entered into a Loan and Security Agreement |
|
| April 20, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 16, 2018 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commi |
|
| February 14, 2018 |
AHPI / Allied Healthcare Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 13, 2017 |
8-K 1 tv4790898k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 9, 2017 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Juris |
|
| November 13, 2017 |
AHPI / Allied Healthcare Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| October 6, 2017 |
Allied Healthcare Products DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| September 28, 2017 |
Form of Power of Attorney – (filed herewith) Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| August 30, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 24, 2017 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 31, 2017 |
Allied Healthcare Products FORM SD SD 1 v468091sd.htm FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri |
|
| May 31, 2017 |
Exhibit 1.01 Conflict Minerals Report This Conflict Minerals Report (?Report?) of Allied Healthcare Products, Inc., a Delaware corporation (?Allied?, the ?Company?, ?we?, or ?us?) for the year ended December 31, 2016 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (?Rule?). Certain terms in this Report are defined in the Rule and our Specialized Disclosure Report o |
|
| May 15, 2017 |
Allied Healthcare Products 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| March 1, 2017 |
Exhibit 99.1 Loan and Security Agreement This Loan and Security Agreement is made and entered into by and between SUMMIT FINANCIAL RESOURCES, L.P., and ALLIED HEALTHCARE PRODUCTS, INC. For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 1. Definitions. Terms defined in the singular shall have the same meaning when used in |
|
| March 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2017 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 14, 2017 |
Allied Healthcare Products FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222207 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| December 6, 2016 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ALLIED HEALTHCARE PRODUCTS, INC. Allied Healthcare Products, Inc. (the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), does hereby adopt this Certificate of Amendment, which amends its Amen |
|
| December 6, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 5, 2016 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2016 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 10, 2016 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) October 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| October 11, 2016 |
Allied Healthcare Products DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| September 23, 2016 |
Allied Healthcare Products PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 23, 2016 |
Exhibit 10.4.2 AGREEMENT This Agreement is made and entered this 1st day of July, 2014, by and between Andrew D. Riley (“Executive”) and Allied Healthcare Products, Inc. WHEREAS, Executive is employed by the Company in a senior management position reporting directly to the Company’s chief executive officer and the Company desires to assure the continued services of Executive prior to and in the ev |
|
| September 23, 2016 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| August 10, 2016 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) July 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| August 10, 2016 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) July 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| May 31, 2016 |
Allied Healthcare Products FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| May 31, 2016 |
Exhibit 1.01 Conflict Minerals Report This Conflict Minerals Report (?Report?) of Allied Healthcare Products, Inc., a Delaware corporation (?Allied?, the ?Company?, ?we?, or ?us?) for the year ended December 31, 2015 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (?Rule?). Certain terms in this Report are defined in the Rule and our Specialized Disclosure Report o |
|
| May 13, 2016 |
Allied Healthcare Products 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| April 6, 2016 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2016 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| February 29, 2016 |
Allied Healthcare Products FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2016 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 9, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| January 27, 2016 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2015 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 13, 2015 |
EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT Exhibit 10.7.1 EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This EIGHTH Amendment to Loan AND SECURITY Agreement (this ?Amendment?), is made as of November 9, 2015, by and between ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation (?Borrower?), and ENTERPRISE BANK & TRUST, a Missouri chartered trust company (?Lender?). WHEREAS, Borrower and Lender have entered into that certain Loan and S |
|
| October 8, 2015 |
Allied Healthcare Products DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| September 30, 2015 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 29, 2015 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (C |
|
| September 25, 2015 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 25, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| May 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| May 29, 2015 |
Exhibit 1.01 Conflict Minerals Report This Conflict Minerals Report (?Report?) of Allied Healthcare Products, Inc., a Delaware corporation (?Allied?, the ?Company?, ?we?, or ?us?) for the year ended December 31, 2014 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (?Rule?). Certain terms in this Report are defined in the Rule and our Specialized Disclosure Report o |
|
| May 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 13, 2015 |
AHPI / Allied Healthcare Products, Inc. / PERRITT CAPITAL MANAGEMENT INC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 5, 2015 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| February 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 13, 2014 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 10, 2014 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) October 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| October 7, 2014 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| October 1, 2014 |
AHPH / ALLIED HEALTHCARE PRODUCTS INC DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Defin |
|
| September 26, 2014 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| June 25, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 17, 2014 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 1720 Sublette Avenue, St. Louis, Missouri (Address of principal exec |
|
| June 2, 2014 |
Exhibit 1.02 Conflict Minerals Report This Conflict Minerals Report (“Report”) of Allied Healthcare Products, Inc., a Delaware corporation (the “Company”) for the year ended December 31, 2013 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (“Rule”). Certain terms in this Report are defined in the Rule and our Specialized Disclosure Report on Form SD and the reader |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 14, 2014 |
AHPI / Allied Healthcare Products, Inc. / PERRITT CAPITAL MANAGEMENT INC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 13, 2014 |
Litigation and Contingencies Critical Accounting Policies UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 13, 2014 |
Allied Healthcare Products Reports Second Quarter Loss Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Second Quarter Loss ST. LOUIS, February 13, 2014 – Continued spending curbs by hospitals and emergency agencies nationwide have resulted in depressed sales for Allied Healthcare Products, Inc. (NASDAQ: AHPI) and a loss in its second quarter of fiscal 2014. The net loss for the quarter endin |
|
| February 10, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| January 28, 2014 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| November 14, 2013 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2013 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 14, 2013 |
1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 14, 2013 1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 14, 2013 FY2013 REVIEW ▪ Continued Impact of Recession on Domestic Markets » Hospitals » Municipalities » Government Spending ▪ International Markets » Flat » Major Drop Off Venezuela ▪ Take Off in CO ₂ Absorbent Business 2 US Hospitals Cutting Manning and Purchases ▪ Medicare, Medicaid, private insurance reducing reimbursements to hospitals » Sequestration cut Medicare reimbursements by 2% ▪ New healthcare law further reduced Medicare payments to hospitals with high readmission rates. |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2013 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction (Commission (IRS Empl |
|
| November 13, 2013 |
Allied Healthcare Products Reports Loss On Depressed Sales EX-99.1 6 v359514ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Loss On Depressed Sales ST. LOUIS, November 13, 2013 – Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss in the first quarter of its 2014 fiscal year on sales depressed by continuing sluggish economic conditions in the hospital market |
|
| November 13, 2013 |
Critical Accounting Policies Item 6. Exhibits 10-Q 1 v35951410q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended September 30, 2013 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number: 0- |
|
| October 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Defin |
|
| October 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 27, 2013 |
Allied Healthcare Products Reports Loss On Sales Decline Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Loss On Sales Decline ST. LOUIS, September 27, 2013 ? Continuing weakness in domestic markets for hospital equipment and a decline in international sales caused a loss for Allied Healthcare Products (NASDAQ: AHPI) in its fourth quarter and for the full fiscal year 2013. The net loss for the |
|
| September 27, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2013 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 27, 2013 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| May 10, 2013 |
Allied Healthcare Products Reports Loss On Depressed Sales EX-99.1 6 v343817ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Loss On Depressed Sales ST. LOUIS, May 10 – The continuing recession in domestic hospital equipment and a dip in international sales resulted in a loss for Allied Healthcare Products (NASDAQ: AHPI) in its third quarter of fiscal year 2013. Net loss f |
|
| May 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| March 29, 2013 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| February 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 25, 2013 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 13, 2013 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 11, 2013 |
AHPI / Allied Healthcare Products, Inc. / PERRITT CAPITAL MANAGEMENT INC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 11, 2013 |
Allied Healthcare Products Reports Second Quarter Loss EX-99.1 6 v332497ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Second Quarter Loss ST. LOUIS, February 11, 2013 – With governmental markets at all levels coping with severe budget constraints, and hospital equipment markets also in recession, Allied Healthcare Products (NASDAQ: AHPI) reported a loss for the seco |
|
| February 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| November 9, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2012 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 8, 2012 |
1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 8, 2012 1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 8, 2012 FY2012 REVIEW ▪ Domestic Hospital, Construction & Emergency Markets Continued to be Hammered by Recession. |
|
| November 8, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2012 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction (Commission (IRS Emplo |
|
| November 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 7, 2012 |
Allied Healthcare Reports First Quarter Loss Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Reports First Quarter Loss ST. LOUIS, November 7, 2012 ? Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss for the first quarter with sales that continue to be dampened by a restrained economy and uncertainties in U.S. healthcare markets about future national policy. The net loss for the first quarter end |
|
| October 9, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| October 9, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Defin |
|
| September 28, 2012 |
EX-10.12 2 v323781ex10-12.htm EXHIBIT 10.12 Exhibit 10.12 PATENT LICENSE AGREEMENT THIS PATENT LICENSE AGREEMENT (“Agreement”) is entered into as of the 8th day of June, 2012 (“Effective Date”) by and between Armstrong Medical Limited., a Northern Ireland company (“Armstrong”) and Allied Healthcare Products, Inc., a Delaware corporation (“Allied”). RECITALS A. Allied and Armstrong are parties to a |
|
| September 28, 2012 |
Allied Healthcare Reports Loss On Depressed Sales Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Reports Loss On Depressed Sales ST. LOUIS, September 28, 2012 ? Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss for the fourth quarter and fiscal year on sales depressed by the lingering effects of recession and uncertainty about future healthcare legislation. Net loss for the fourth quarter ending June |
|
| September 28, 2012 |
10-K 1 v32378110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-192 |
|
| September 28, 2012 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| June 13, 2012 |
Entry into a Material Definitive Agreement - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 8, 2012 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 5, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2012 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 10, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| May 10, 2012 |
Allied Healthcare Products Reports Loss on Sales Decline EX-99.1 6 v310279ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Loss on Sales Decline ST. LOUIS, May 10, 2012 – Challenged by weak demand in its domestic markets, Allied Healthcare Products Inc. (NASDAQ: AHPI) reported a loss for the third quarter of fiscal year 2012 on a decline in sales. Net income for the quar |
|
| February 14, 2012 |
AHPI / Allied Healthcare Products, Inc. / PERRITT CAPITAL MANAGEMENT INC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q 1 v30019110q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended December 31, 2011 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to Commission File Number: 0-1 |
|
| February 13, 2012 |
Allied Healthcare Products Reports Break-even Quarter EX-99.1 6 v300191ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Break-even Quarter ST. LOUIS, February 13, 2012 – With its markets still facing tight budget constraints, Allied Healthcare Products (NASDAQ: AHPI) reported break-even results for the second quarter of fiscal year 2012. Net income for the quarter end |
|
| January 24, 2012 |
AHPI / Allied Healthcare Products, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| January 23, 2012 |
AHPI / Allied Healthcare Products, Inc. / WEIL JOHN D - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222 10 8 (CUSIP Number) John D. Weil 200 N. Broadway Suite 825 St. Louis, Missouri 63102 (314) 421-4600 (Name, Address and Telephone Number of Person Authorized to Receive Noti |
|
| November 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2011 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2011 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 10, 2011 |
1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 10, 2011 1 ALLIED HEALTHCARE ANNUAL SHAREHOLDER MEETING November 10, 2011 ALLIED SALES PATTERN DURING RECESSION FY 2008 FY2009 FY2010 FY 2011 Sales $56. |
|
| November 9, 2011 |
As filed with the Securities and Exchange Commission on November 9, 2011 Registration No. |
|
| November 8, 2011 |
Allied Healthcare Products Reports First Quarter Loss On Sales Decline EX-99.1 6 v238658ex99-1.htm EX-99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports First Quarter Loss On Sales Decline ST. LOUIS, November 8, 2011 – Allied Healthcare Products, Inc. (NASDAQ: AHPI) reported a loss in its first quarter on a decline in sales. Allied’s net loss for the first quarter of its 2012 fiscal year was approximately |
|
| November 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| October 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| September 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2011 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 27, 2011 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| September 2, 2011 |
Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession EX-99.1 2 v234083ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession ST. LOUIS, September 2, 2011 – Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a profitable fourth quarter and fiscal year despite sluggish sales to hospitals and government entities |
|
| September 2, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 2, 2011 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| May 6, 2011 |
Allied Healthcare Earns Modest Profit in Tight Market Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Earns Modest Profit in Tight Market ST. LOUIS, May 6, 2011 ? With tight budgets continuing to constrain its healthcare markets, Allied Healthcare Products (NASDAQ: AHPI) reported a modest profit in the third quarter of fiscal year 2011 and further improvement in its year-over-year performance. Net income fo |
|
| May 6, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Allied Healthcare Products, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 8, 2011 |
ALLIED HEALTHCARE PRODUCTS, INC. CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Modest Profit for Quarter ST. LOUIS, February 8, 2011 ? With its governmental markets still depressed, Allied Healthcare Products (NASDAQ: AHPI) earned a modest profit in the second quarter of fiscal year 2011 and improvement in its year-over-year performance. Net income for the quarter end |
|
| January 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| November 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2010 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 11, 2010 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 12, 2010 | ||
| November 5, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 5, 2010 |
Allied Healthcare Products Reports Narrow Loss for Quarter But Improves Year-Over-Year Performance Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Reports Narrow Loss for Quarter But Improves Year-Over-Year Performance ST. LOUIS, November 5, 2010 ? Despite difficult economic conditions, Allied Healthcare Products (NASDAQ: AHPI) managed to increase sales by 5.3 percent in the first quarter of fiscal year 2011. Sales increased by $600,000 to to |
|
| October 7, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| September 23, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year June 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19266 ALLIED HEALTHCARE PRODUCTS, INC. |
|
| September 23, 2010 |
Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below constitutes and appoints Earl R. |
|
| August 30, 2010 |
Recession Leads to Sales Decline and Loss For Allied Healthcare Products in Fiscal 2010 Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Recession Leads to Sales Decline and Loss For Allied Healthcare Products in Fiscal 2010 ST. Louis, August 30, 2010 ? Recession-driven budget cuts by hospitals and governmental entities reduced sales for Allied Healthcare Products, Inc. (NASDAQ: AHPI) throughout fiscal 2010. The company managed to offset much of the year?s sa |
|
| August 30, 2010 |
Results of Operations and Financial Condition, Financial Statements and Exhibits 8-K 1 v1955728k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 30, 2010 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware 0-19266 25-1370721 (State or Other Jurisdiction of |
|
| May 7, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| May 7, 2010 |
Allied Healthcare Products Offsets Sales Declines With Cost Reductions for Break-Even Quarter Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Offsets Sales Declines With Cost Reductions for Break-Even Quarter ST. LOUIS, May 7, 2010 ? Budget constraints for hospitals and municipalities continued to depress sales for Allied Healthcare Products, Inc. (NASDAQ: AHPI) but the company managed to improve its third quarter results over last year? |
|
| May 7, 2010 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is made and entered into effective as of the 21st day of December, 2009, (the "Effective Date") by and between EARL REFSLAND a resident of Missouri ("Executive") and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation, for itself and on behalf of any of its current or future subsidiary corporations (collectively referre |
|
| February 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| February 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* ALLIED HEALTHCARE PRODUCTS (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 8, 2010 |
Contact: Daniel C. Dunn Chief Financial Officer 314/771-2400 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions ST. LOUIS, February 8, 2010 ? Cost reductions offset a recession-driven sales decline to move Allied Healthcare Products (NASDAQ: AHPI) narrowly back into profitability in the second quarter of fiscal year 2010. Sales for the quarter en |
|
| January 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6) ALLIED HEALTHCARE PRODS INC (Name of Issuer) COM (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| January 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ALLIED HEALTHCARE PRODUCTS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 019222108 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to whi |
|
| November 18, 2009 |
REVOLVING CREDIT NOTE $7,500,000 November 17, 2009 EXHIBIT 99.2 REVOLVING CREDIT NOTE $7,500,000 November 17, 2009 FOR VALUE RECEIVED, the undersigned, ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation with its chief executive office and principal place of business at 1720 Sublette Avenue, St. Louis, Missouri 63110 (?Borrower"), promises to pay to the order of ENTERPRISE BANK & TRUST (?Lender"), at the office of the Lender, located at 150 N |
|
| November 18, 2009 |
EXHIBIT 99.1 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT is made this day of November 17, 2009, by and between ENTERPRISE BANK & TRUST (?Lender?), a Missouri chartered trust company with an office at 150 N. Meramec, Clayton, Missouri 63105; and ALLIED HEALTHCARE PRODUCTS, INC. (?Borrower?), a Delaware corporation with its chief executive office and principal place of business at 1 |
|
| November 18, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 13, 2009 ALLIED HEALTHCARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 0-19266 (Commission Fi |
|
| November 6, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|
| November 6, 2009 |
Recession Continues to Depress Sales at Allied Healthcare Products Exhibit 99.1 Contact: Daniel C. Dunn Chief Financial Officer (314) 771-2400 Recession Continues to Depress Sales at Allied Healthcare Products ST. LOUIS, November 6, 2009 ? Recession in domestic and international markets continued to depress sales for Allied Healthcare Products in the first quarter of fiscal year 2010 ending September 30, 2009. Sales declines pushed Allied into a loss for the quar |
